Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

Timing is everything, right? Diabetes educators explain when they eat their first meal to manage their blood sugars.

A recent study from Western Sydney University has shown that a simple change in how healthcare providers manage type 2 ...

Austin High senior Alexis Jordan knew she had to instill discipline in her life and refrain from previous lifestyle choices ...

More than 57,000 people in West Sussex are living with diabetes, councillors have been told. The information was shared during a meeting of the county council’s health & adult social care scrutiny ...

As Novo Nordisk rakes in billions, Sen. Bernie Sanders and public health advocates demand answers on why U.S. patients are charged sky-high prices for life-saving drugs like Ozempic while generics ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.

The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a single sensor rather than the 10 days to two weeks typical for wearable ...

Nearly 4.4 million adult New Yorkers, or 30%, has obesity, but access to weight-loss medications varies based on a variety of ...

Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.